Skip to content
  • Firm
    • About Us
    • Equality, Diversity & Inclusion
    • Firm Facts
    • Alumni
    • Timeline
    • WeirFoulds Women
  • Insight & News
    • Publications
    • News
    • In The Media
    • Blogs
    • Podcasts
  • Events
  • Careers
    • Overview
    • Students
    • Lawyers
    • Staff
  • Contact Us
ONLINE PAYMENT
SEARCH SITE
WeirFoulds LLP
WeirFoulds LLPWeirFoulds LLP
SEARCH
PEOPLE
BROWSE BY
PRACTICE
Search People
  • Search

  • Practice Area

  • Directory

  • Role

  • Administrative & Public Law
  • Aviation and Transportation
  • Banking & Financial Services
  • Cannabis
  • Caribbean & Offshore
  • Charities & Non-Profits
  • Commercial Leasing
  • Commercial Litigation
  • Construction
  • Corporate & Commercial
  • Design-Build
  • Employment & Labour
  • Energy & Utilities
  • Environmental
  • Expropriation
  • Health Care
  • Human Rights
  • Indigenous Peoples
  • Infrastructure/P3
  • Insolvency & Restructuring
  • Litigation & Dispute Resolution
  • Media and Defamation
  • Mergers & Acquisitions
  • Mining
  • Municipal
  • Planning & Land Development
  • Privacy & Access to Information
  • Private Equity
  • Procurement
  • Public Companies
  • Real Property
  • Regulated Professions and Industries
  • Securities
  • Sports
  • Subrogation & Recovery
  • Tax
  • Technology & Intellectual Property
  • Universities & Colleges
  • Wills, Trusts & Estates
  • Zoning & Official Plans
  • Search
    People
  • Browse by
    Practice
  • Firm
    • About Us
    • Equality, Diversity & Inclusion
    • Firm Facts
    • Alumni
    • Timeline
    • WeirFoulds Women
  • Insight & News
    • Publications
    • News
    • In The Media
    • Blogs
    • Podcasts
  • Events
  • Careers
    • Careers Overview
    • Students
    • Lawyers
    • Staff
  • Contact Us
  • Blog
  • Online Payment

Ann Lattanzio

You are here:
  1. Home
Feb 25, 2021

WeirFoulds represents Antibe Therapeutics in a $40M public offering

On February 24, 2020, Antibe Therapeutics Inc. (“Antibe”) (TSX: ATE) announced that it closed a bought deal public offering of 6,727,500 units (the “Units”) raising aggregate gross…

Dec 8, 2020

WeirFoulds represents StageZero Life Sciences Ltd. in $7.2M public offering

On December 4, 2020, StageZero Life Sciences Ltd. (“StageZero”) (TSX: SZLS) announced that it closed its previously announced public offering of 9,243,700 units (the “Units”) raising aggregate…

Jul 7, 2020

WeirFoulds represents StageZero Life Sciences Ltd. in $4.6M public offering

On June 29, 2020, StageZero Life Sciences Ltd. (“StageZero”) (TSX: SZLS) completed a public offering of 66,176,100 units (the “Units”) at a price of $0.07 per Unit…

Jun 30, 2020

WeirFoulds represents Antibe Therapeutics in $28.75M bought deal public offering

On June 30, 2020, Antibe Therapeutics Inc. (“Antibe”) (TSXV: ATE) announced that it closed its previously announced bought deal public offering of units (the “Units”) raising aggregate gross proceeds…

Mar 30, 2020

Blanket Relief for Certain Regulatory Filings as a Result of COVID-19

As previously discussed, the Canadian Securities Administrators (the “CSA“) issued notices laying out measures the CSAs would take in order to assist market participants with the challenges…

Mar 20, 2020

COVID-19 Updates: Canadian Securities Regulators and Exchanges

As the world fights to stop the spread of COVID-19 by implementing social distancing measures, companies are faced with the challenges of ensuring the health and safety…

Aug 1, 2019

WeirFoulds represents XAU Resources Inc. in recent IPO

On July 18, 2019, XAU Resources Inc. (TSXV: GIG.P) announced its completion of an initial public offering of 4,411,500 common shares of the Corporation (the “Common Shares”)…

May 1, 2019

WeirFoulds simplifies registration process for dealers and advisors

From complex forms and documents to tax and other commercial issues, the registration process of dealers and advisors comes with a variety of risks and challenges. WeirFoulds…

Mar 11, 2019

WeirFoulds represents Antibe Therapeutics Inc. in completion of $5.75-million bought deal public offering

On February 27, 2019, Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF) announced that it closed its previously announced bought deal public offering of 23,000,000 units of the…

Dec 21, 2018

WeirFoulds represents Harte Gold in Comprehensive US$70 Million Debt Financing Package

On June 1, 2018, Harte Gold Corp. (“Harte Gold” or the “Company”) (TSX: HRT / OTC: HRTFF / Frankfurt: H4O) announced it has closed the US$70 million…

Sep 24, 2018

CSA Amendments to Simplify Reports of Exempt Distribution – Bulletin

On July 19, 2018, the Canadian Securities Administrators (“CSA“) published final amendments (“Amendments“) to National Instrument 45-106 – Prospectus Exemptions (“NI 45-106“) and its related Companion Policy…

May 24, 2018

Is Your RAQ Ready? 2018 Risk Assessment Questionnaire (RAQ) Due Dates are Coming Up

The Ontario Securities Commission (OSC) conducts examinations of registrant firms with respect to their compliance with regulatory requirements. The OSC gathers information about each firm including as…

Jul 5, 2017

WeirFoulds Represents Harte Gold in the Closing of a $25 Million Bought Deal Private Placement

On Tuesday, July 5, 2017, Harte Gold Corp. (the “Company”) (TSX: HRT / OTC: HRTFF/ Frankfurt: H4O) completed its previously announced bought deal private placement financing, selling…

Jul 25, 2016

WeirFoulds Securities Law Quarterly: Concise, Informative Updates on Securities Law Developments for the Canadian Marketplace – Q2 2016

Our coverage is succinct and targeted to serve the needs of issuers and their advisors. For more detailed information on our service offerings, please visit us online…

Feb 4, 2016

WeirFoulds Represents Honeywell in the Acquisition of COM DEV International’s Space Hardware and Systems Business

On Thursday, February 4, 2016, Honeywell (NYSE:HON) completed the previously announced acquisition by plan of arrangement of COM DEV International Ltd. (TSX:CDV), a leading satellite and space components provider of switches and multiplexers.

Oct 14, 2011

Amendments to Executive Compensation Disclosure Requirements

The Canadian Securities Administrators are adopting amendments to the Statement of Executive Compensation. These changes come into force on October 31, 2011.

  • Refine by:

WeirFoulds LLP
WeirFoulds LLP
Subscribe to our newsletters

Get up to date information directly to your inbox

SUBSCRIBE NOW!

Toronto Office
4100 – 66 Wellington St. W.
PO Box 35, TD Bank Tower
Toronto, ON Canada
M5K 1B7

TEL: 416-365-1110
FAX: 416-365-1876

Oakville Office
1525 Cornwall Rd, Suite 10
Oakville, ON Canada
L6J 0B2

TEL: 416-365-1110
FAX: 905-829-2035

ACCESSIBILITY
Visit WeirFoulds on TwitterVisit WeirFoulds on LinkedInVisit WeirFoulds on YouTube
Copyright © 2023. WeirFoulds LLP. All rights reserved. Prior results do not guarantee a similar outcome.

Terms Of Use | Privacy Policy | Website development by Gosek